Xbrane Biopharma AB (publ) (STO:XBRANE)

Xbrane Biopharma AB Revenue

In the year 2025, Xbrane Biopharma AB had annual revenue of 152.35M SEK, down -23.33%. Xbrane Biopharma AB had revenue of 9.09M in the quarter ending December 31, 2025, a decrease of -86.19%.

• Revenue: 152.35M
• Revenue Growth: -23.33%
• P/S Ratio: 0.83
• Revenue / Employee: 5.86M
• Employees: 26
• Market Cap: 126.13M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	152.35M	-46.37M	-23.33%
Dec 31, 2024	198.72M	-40.01M	-16.76%
Dec 31, 2023	238.73M	181.11M	314.33%
Dec 31, 2022	57.62M	46.91M	438.03%
Dec 31, 2021	10.71M	-	-